Fmr LLC Travere Therapeutics, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 115,644 shares of TVTX stock, worth $2.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

115,644

Previous 75,828 52.51%

Holding current value

$2.3 Million

Previous $584,000 62.67%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$5.26 - $8.28 $209,432 - $329,676	39,816 Added 52.51%	115,644 $950,000
Q1 2024 May 13, 2024	SELL	$7.18 - $9.82 $7,438 - $10,173	-1,036 Reduced 1.35%	75,828 $584,000
Q4 2023 Feb 13, 2024	SELL	$5.44 - $9.5 $48,932 - $85,452	-8,995 Reduced 10.48%	76,864 $691,000
Q3 2023 Nov 13, 2023	BUY	$7.64 - $17.25 $184,697 - $417,018	24,175 Added 39.19%	85,859 $767,000
Q2 2023 Aug 11, 2023	SELL	$15.3 - $22.61 $2.36 Million - $3.48 Million	-154,076 Reduced 71.41%	61,684 $947,000
Q1 2023 May 11, 2023	BUY	$17.82 - $22.89 $634,267 - $814,723	35,593 Added 19.76%	215,760 $4.85 Million
Q4 2022 Feb 13, 2023	SELL	$18.47 - $26.14 $4.41 Million - $6.24 Million	-238,738 Reduced 56.99%	180,167 $3.79 Million
Q3 2022 Nov 10, 2022	SELL	$22.91 - $28.63 $456,115 - $569,994	-19,909 Reduced 4.54%	418,905 $10.3 Million
Q2 2022 Aug 12, 2022	BUY	$20.94 - $30.01 $431,992 - $619,106	20,630 Added 4.93%	438,814 $10.6 Million
Q1 2022 May 13, 2022	BUY	$23.61 - $30.6 $1.07 Million - $1.38 Million	45,256 Added 12.14%	418,184 $10.8 Million
Q3 2021 Nov 15, 2021	BUY	$12.98 - $25.03 $4.68 Million - $9.03 Million	360,629 Added 2932.18%	372,928 $9.04 Million
Q2 2021 Aug 13, 2021	BUY	$14.11 - $26.4 $173,538 - $324,693	12,299 New	12,299 $179,000

Others Institutions Holding TVTX

# of Institutions

187

Shares Held

89.5M

Call Options Held

137K

Put Options Held

184K

View Full List

About Travere Therapeutics, Inc.

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.27B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

More about TVTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account